Local renin-angiotensin system and the brain - A continuous quest for knowledge

Peptides

Volumn 32, Issue 5, 2011, Pages 1083-1086

  Baltatu, Ovidiu C ^a,b   Campos, Luciana A ^a,b   Bader, Michael ^c  

^a UNIVERSIDADE CAMILO CASTELO BRANCO   (Brazil)

^b GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Angiotensin; Renin

Indexed keywords

PRORENIN RECEPTOR; RENIN;

AGING; BLOOD PRESSURE REGULATION; BRAIN; BRAIN FUNCTION; CARDIOVASCULAR FUNCTION; ELECTROLYTE BALANCE; FLUID BALANCE; HOMEOSTASIS; HUMAN; HYPOPHYSIS TUMOR; KIDNEY FUNCTION; METABOLIC SYNDROME X; NONHUMAN; OBESITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

ANIMALS; BRAIN; HUMANS; METABOLIC SYNDROME X; NEUROSCIENCES; RENIN-ANGIOTENSIN SYSTEM;

EID: 79955466909     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2011.02.008     Document Type: Review

References (85)

1. J.L. Abramson, C. Lewis, and N.V. Murrah Body mass index, leptin, and ambulatory blood pressure variability in healthy adults Atherosclerosis 214 2011 456 461
2. C. Anderson, K. Teo, P. Gao, H. Arima, A. Dans, and T. Unger Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies Lancet Neurol 10 2011 43 53
3. M. Bader Tissue renin-angiotensin-aldosterone systems: targets for pharmacological therapy Annu Rev Pharmacol Toxicol 50 2010 439 465
4. M. Bader, and D. Ganten Update on tissue renin-angiotensin systems J Mol Med 86 2008 615 621
5. O. Baltatu, S.C. Afeche, S.H. Jose dos Santos, L.A. Campos, R. Barbosa, and L.C. Michelini Locally synthesized angiotensin modulates pineal melatonin generation J Neurochem 80 2002 328 334 (Pubitemid 34809378)
6. O. Baltatu, and M. Bader Brain renin-angiotensin system. Lessons from functional genomics Neuroendocrinology 78 2003 253 259 (Pubitemid 37505822)
7. O. Baltatu, L.A. Campos, and M. Bader Genetic targeting of the brain renin-angiotensin system in transgenic rats: impact on stress-induced renin release Acta Physiol Scand 181 2004 579 584 (Pubitemid 39078857)
8. O. Baltatu, B.J. Janssen, G. Bricca, R. Plehm, J. Monti, and D. Ganten Alterations in blood pressure and heart rate variability in transgenic rats with low brain angiotensinogen Hypertension 37 2001 408 413 (Pubitemid 32199002)
9. O. Baltatu, A. Lippoldt, A. Hansson, D. Ganten, and M. Bader Local renin-angiotensin system in the pineal gland Brain Res Mol Brain Res 54 1998 237 242 (Pubitemid 28171787)
10. J. Bohlender, J. Menard, J. Wagner, F.C. Luft, and D. Ganten Human renin-dependent hypertension in rats transgenic for human angiotensinogen Hypertension 27 1996 535 540 (Pubitemid 26084621)
11. J.A. Brown, C.S. Cobb, S.C. Frankling, and J.C. Rankin Activation of the newly discovered cyclostome renin-angiotensin system in the river lamprey Lampetra fluviatilis J Exp Biol 208 2005 223 232 (Pubitemid 40307226)
12. S.M. Caligiorne, A.Q. Silva, M.A. Fontes, J.R. Silva, O. Baltatu, and M. Bader Baroreflex control of heart rate and renal sympathetic nerve activity in rats with low brain angiotensinogen Neuropeptides 42 2008 159 168
13. L.A. Campos, R. Plehm, J. Cipolla-Neto, M. Bader, and O.C. Baltatu Altered circadian rhythm reentrainment to light phase shifts in rats with low levels of brain angiotensinogen Am J Physiol Regul Integr Comp Physiol 290 2006 R1122 R1127
14. D. Cardinale, A. Colombo, M.T. Sandri, G. Lamantia, N. Colombo, and M. Civelli Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition Circulation 114 2006 2474 2481 (Pubitemid 44901520)
15. C.C. Cardoso, N. Alenina, A.J. Ferreira, F. Qadri, M.P. Lima, and V. Gross Increased blood pressure and water intake in transgenic mice expressing rat tonin in the brain Biol Chem 391 2010 435 441
16. R.M. Carey, and H.M. Siragy Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation Endocr Rev 24 2003 261 271 (Pubitemid 36733542)
17. C.S. Cobb, J.A. Brown, and J.C. Rankin Antidiuretic action of angiotensin II in the river lamprey Lampetra fluviatilis: evidence for endocrine control of kidney function in cyclostomes J Fish Biol 77 2010 1424 1431
18. A.D. de Kloet, E.G. Krause, and S.C. Woods The renin angiotensin system and the metabolic syndrome Physiol Behav 100 2010 525 534
19. T.H. Do, Y. Chen, V.T. Nguyen, and S. Phisitkul Vaccines in the management of hypertension Exp Opin Biol Ther 10 2010 1077 1087
20. M. Doumas, and S. Douma Renal sympathetic denervation: the jury is still out Lancet 376 2010 1878 1880
21. M.D. Esler, H. Krum, P.A. Sobotka, M.P. Schlaich, R.E. Schmieder, and M. Bohm Renal sympathetic denervation in patients with treatment-resistant hypertension (the symplicity HTN-2 trial): a randomised controlled trial Lancet 376 2010 1903 1909
22. S.H. Ferreira A bradykinin-potentiating factor (Bpf) present in the venom of Bothrops jararca Br J Pharmacol Chemother 24 1965 163 169
23. S.H. Ferreira, L.H. Greene, V.A. Alabaster, Y.S. Bakhle, and J.R. Vane Activity of various fractions of bradykinin potentiating factor against angiotensin I converting enzyme Nature 225 1970 379 380
24. F. Fyhrquist, and O. Saijonmaa Renin-angiotensin system revisited J Intern Med 264 2008 224 236
25. D. Ganten, U. Ganten, P. Schelling, R. Boucher, and J. Genest The renin and iso-renin-angiotensin system in rats with experimental pitutary tumors (38585) Proc Soc Exp Biol Med 148 1975 568 572
26. D. Ganten, K. Hayduk, H.M. Brecht, R. Boucher, and J. Genest Evidence of renin release or production in splanchnic territory Nature 226 1970 551 552
27. D. Ganten, J.L. Minnich, P. Granger, K. Hayduk, H.M. Brecht, and A. Barbeau Angiotensin-forming enzyme in brain tissue Science 173 1971 64 65
28. D. Ganten, J. Wagner, K. Zeh, M. Bader, J.B. Michel, and M. Paul Species specificity of renin kinetics in transgenic rats harboring the human renin and angiotensinogen genes Proc Natl Acad Sci USA 89 1992 7806 7810
29. C. Geeganage, M. Tracy, T. England, G. Sare, T. Moulin, and F. Woimant Relationship between baseline blood pressure parameters (including mean pressure, pulse pressure, and variability) and early outcome after stroke: data from the tinzaparin in acute ischaemic stroke trial (TAIST) Stroke 42 2011 491 493
30. A.J. George, W.G. Thomas, and R.D. Hannan The renin-angiotensin system and cancer: old dog, new tricks Nat Rev Cancer 10 2010 745 759
31. H. Goldblatt, E. Haas, and H. Lamfrom Antirenin in man and animals Trans Assoc Am Physicians 64 1951 122 125
32. R. Goschke, R. Rasetti, N.C. Cohen, J. Rahuel, M.G. Gruetter, and S. Stutz Novel 2,7-dialkyl substituted 5(S)-amino-4(S)-hydroxy-8-phenyl-octan- ecarboxamide transition state peptidomimetics are potent and orally active inhibitors of human renin The XVth EFMC International Symposium on Medicinal Chemistry Edinburgh, U.K. 1998 P229
33. G. Grassi, F. Quarti-Trevano, G. Brambilla, and G. Seravalle Blood pressure control in resistant hypertension: new therapeutic options Expert Rev Cardiovasc Ther 8 2010 1579 1585
34. P. Gratze, M. Boschmann, R. Dechend, F. Qadri, J. Malchow, and S. Graeske Energy metabolism in human renin-gene transgenic rats: does renin contribute to obesity? Hypertension 53 2009 516 523
35. J.L. Grobe, C.L. Grobe, T.G. Beltz, S.G. Westphal, D.A. Morgan, and D. Xu The brain renin-angiotensin system controls divergent efferent mechanisms to regulate fluid and energy balance Cell Metab 12 2010 431 442
36. J.L. Grobe, D. Xu, and C.D. Sigmund An intracellular renin-angiotensin system in neurons: fact, hypothesis, or fantasy Physiology (Bethesda) 23 2008 187 193
37. T. Hengelage, P. Herold, C. Jensen, and O.C. Baltatu Efficacy and Safety of the Oral Renin Inhibitor SPP635 Once Daily in Patients with Mild to Moderate Hypertension Hypertension 2008, Joint Congress 18th Scientific Meeting of the European Society of Hypertension and the 22nd Scientific Meeting of the International Society of Hypertension Berlin, Germany 2008
38. K. Heusser, J. Tank, S. Engeli, A. Diedrich, J. Menne, and S. Eckert Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients Hypertension 55 2010 619 626
39. T. Hoi-Hansen, U. Pedersen-Bjergaard, R.D. Andersen, P.L. Kristensen, C. Thomsen, and T. Kjaer Cognitive performance, symptoms and counter-regulation during hypoglycaemia in patients with type 1 diabetes and high or low renin-angiotensin system activity J Renin Angiotensin Aldosterone Syst 10 2009 216 229
40. R.A. Hong, T. Iimura, K.N. Sumida, and R.M. Eager Cardio-oncology/onco- cardiology Clin Cardiol 33 2010 733 737
41. H. Kai, H. Kudo, N. Takayama, S. Yasuoka, H. Kajimoto, and T. Imaizumi Large blood pressure variability and hypertensive cardiac remodeling - role of cardiac inflammation Circ J 73 2009 2198 2203
42. N. Kalay, E. Basar, I. Ozdogru, O. Er, Y. Cetinkaya, and A. Dogan Protective effects of carvedilol against anthracycline-induced cardiomyopathy J Am Coll Cardiol 48 2006 2258 2262 (Pubitemid 44855419)
43. P.G. Kehoe, S. Miners, and S. Love Angiotensins in Alzheimer's disease - friend or foe? Trends Neurosci 32 2009 619 628
44. K. Kondo, T. Saruta, R. Garcia, and R. Boucher The effects of intracerebroventricular administration of tonin on water drinking and blood pressure in rats Endocrinol Jpn 27 1980 567 571
45. J.L. Lavoie, X. Liu, R.A. Bianco, T.G. Beltz, A.K. Johnson, and C.D. Sigmund Evidence supporting a functional role for intracellular renin in the brain Hypertension 47 2006 461 466 (Pubitemid 43740291)
46. F.C. Luft Divergent effects of central and peripheral renin on body weight and metabolism Cell Metab 12 2010 423 424
47. S. Masuda, K. Tamura, H. Wakui, T. Kanaoka, M. Ohsawa, and A. Maeda Effects of angiotensin II type 1 receptor blocker on ambulatory blood pressure variability in hypertensive patients with overt diabetic nephropathy Hypertens Res 32 2009 950 955
48. A.R. Michell Blood pressure measurement, single measurements would not withstand 21st century peer review BMJ 323 2001 805 806
49. A.R. Michell Prognostic significance of blood-pressure variability Lancet 376 2010 413 author reply 4-5
50. H. Nakamae, K. Tsumura, Y. Terada, T. Nakane, M. Nakamae, and K. Ohta Notable effects of angiotensin II receptor blocker, valsartan, on acute cardiotoxic changes after standard chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisolone Cancer 104 2005 2492 2498 (Pubitemid 41691573)
51. G. Nguyen Renin and prorenin receptor in hypertension: what's new? Curr Hypertens Rep 13 2011 79 85
52. G. Nguyen, F. Delarue, C. Burckle, L. Bouzhir, T. Giller, and J.D. Sraer Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin J Clin Invest 109 2002 1417 1427 (Pubitemid 34596167)
53. R. Pandey, W.Y. Quan, F. Hong, and S.L. Jie Vaccine for hypertension: modulating the renin-angiotensin system Int J Cardiol 134 2009 160 168
54. M. Paul, A. Poyan Mehr, and R. Kreutz Physiology of local renin-angiotensin systems Physiol Rev 86 2006 747 803 (Pubitemid 44033382)
55. L. Paulis, and T. Unger Novel therapeutic targets for hypertension Nat Rev Cardiol 7 2010 431 441
56. N. Pelisch, N. Hosomi, M. Ueno, D. Nakano, H. Hitomi, and M. Mogi Blockade of AT1 receptors protects the blood-brain barrier and improves cognition in dahl salt-sensitive hypertensive rats Am J Hypertens 24 2011 362 368
57. B. Pilz, E. Shagdarsuren, M. Wellner, A. Fiebeler, R. Dechend, and P. Gratze Aliskiren, a human renin inhibitor, ameliorates cardiac and renal damage in double-transgenic rats Hypertension 46 2005 569 576 (Pubitemid 41376839)
58. J. Ramser, F.E. Abidi, C.A. Burckle, C. Lenski, H. Toriello, and G. Wen A unique exonic splice enhancer mutation in a family with X-linked mental retardation and epilepsy points to a novel role of the renin receptor Hum Mol Genet 14 2005 1019 1027 (Pubitemid 40575877)
59. J.C. Rankin, C.S. Cobb, S.C. Frankling, and J.A. Brown Circulating angiotensins in the river lamprey, Lampetra fluviatilis, acclimated to freshwater and seawater: possible involvement in the regulation of drinking Comp Biochem Physiol B Biochem Mol Biol 129 2001 311 318 (Pubitemid 32523953)
60. D.A. Reardon, J.N. Rich, H.S. Friedman, and D.D. Bigner Recent advances in the treatment of malignant astrocytoma J Clin Oncol 24 2006 1253 1265 (Pubitemid 46622028)
61. G. Reboldi, G. Gentile, F. Angeli, and P. Verdecchia Pharmacokinetic, pharmacodynamic and clinical evaluation of aliskiren for hypertension treatment Expert Opin Drug Metab Toxicol 7 2011 115 128
62. G. Riviere, A. Michaud, H.R. Corradi, E.D. Sturrock, K. Ravi Acharya, and V. Cogez Characterization of the first angiotensin-converting like enzyme in bacteria: ancestor ACE is already active Gene 399 2007 81 90 (Pubitemid 47069803)
63. M.E. Robbins, W. Zhao, M.A. Garcia-Espinosa, and D.I. Diz Renin-angiotensin system blockers and modulation of radiation-induced brain injury Curr Drug Targets 11 2010 1413 1422
64. P.M. Rothwell Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension Lancet 375 2010 938 948
65. P.M. Rothwell, S.C. Howard, E. Dolan, E. O'Brien, J.E. Dobson, and B. Dahlof Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension Lancet 375 2010 895 905
66. M.F. Rubin, S.M. Brunelli, and R.R. Townsend Variability - the drama of the circulation J Clin Hypertens (Greenwich) 12 2010 284 287
67. J.M. Saavedra, E. Sanchez-Lemus, and J. Benicky Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: therapeutic implications Psychoneuroendocrinology 36 2011 1 18
68. P. Schelling, H. Fischer, J. Hutchinson, and D. Ganten Proceedings: influence of angiotensin II and angiotensin II antagonist (P 113) in vitro on cell growth in 3T3 and virus transformed SV40 3T3 cells Naunyn Schmiedebergs Arch Pharmacol 287 Suppl 1975 R51
69. P. Schelling, D. Ganten, Z. Nemes, and H. Fischer Effects of angiotensin II and of an angiotensin II receptor antagonist on simian virus 40-induced tumor growth in vivo Experientia 36 1980 452 454 (Pubitemid 10081666)
70. M. Schinke, O. Baltatu, M. Bohm, J. Peters, W. Rascher, and G. Bricca Blood pressure reduction and diabetes insipidus in transgenic rats deficient in brain angiotensinogen Proc Natl Acad Sci USA 96 1999 3975 3980 (Pubitemid 29169021)
71. G. Sihn, A. Rousselle, L. Vilianovitch, C. Burckle, and M. Bader Physiology of the (pro)renin receptor: want of change? Kidney Int 78 2010 246 256
72. A. Soylu, M. Yazici, M.A. Duzenli, M. Tokac, K. Ozdemir, and H. Gok Relation between abnormalities in circadian blood pressure rhythm and target organ damage in normotensives Circ J 73 2009 899 904
73. J. Stegbauer, and T.M. Coffman New insights into angiotensin receptor actions: from blood pressure to aging Curr Opin Nephrol Hypertens 20 2011 84 88
74. E. Szczepanska-Sadowska, A. Cudnoch-Jedrzejewska, M. Ufnal, and T. Zera Brain and cardiovascular diseases: common neurogenic background of cardiovascular, metabolic and inflammatory diseases J Physiol Pharmacol 61 2010 509 521
75. M. Tatokoro, Y. Fujii, S. Kawakami, N. Fukui, Y. Komai, and K. Saito Favorable response to combination treatment of cimetidine, cyclooxygenase-2 inhibitor and renin-angiotensin system inhibitor in metastatic renal cell carcinoma: report of three cases Int J Urol 15 2008 848 850
76. M. Tatokoro, Y. Fujii, S. Kawakami, K. Saito, F. Koga, and Y. Matsuoka Phase-II trial of combination treatment of interferon-alpha, cimetidine, cyclooxygenase-2 inhibitor and renin-angiotensin-system inhibitor (I-CCA therapy) for advanced renal cell carcinoma Cancer Sci 102 2011 137 143
77. R. Tigerstedt, and P.G. Bergman Niere und kreislauf Scand Arch Physiol 8 1898 223 270
78. R. Virtanen, A. Jula, T. Kuusela, H. Helenius, and L.M. Voipio-Pulkki Reduced heart rate variability in hypertension: associations with lifestyle factors and plasma renin activity J Hum Hypertens 17 2003 171 179
79. R.L. Webb, N. Schiering, R. Sedrani, and J. Maibaum Direct renin inhibitors as a new therapy for hypertension J Med Chem 53 2010 7490 7520
80. C. Werner, J. Poss, and M. Bohm Optimal antagonism of the renin-angiotensin-aldosterone system: do we need dual or triple therapy? Drugs 70 2010 1215 1230
81. W.B. White, R. Bresalier, A.P. Kaplan, B.F. Palmer, R.H. Riddell, and A. Lesogor Safety and tolerability of the direct renin inhibitor aliskiren: a pooled analysis of clinical experience in more than 12,000 patients with hypertension J Clin Hypertens (Greenwich) 12 2010 765 775
82. J. Wong, L. Molyneaux, M. Constantino, S.M. Twigg, and D.K. Yue Beyond ONTARGET: angiotensin-converting enzyme inhibition and angiotensin II receptor blockade in combination, a lesser evil in some? Diabetes Obes Metab 12 2010 1072 1078
83. Xu D, G.R. Borges, D.R. Davis, K. Agassandian, M.L. Sequeira Lopez, and R.A. Gomez Neuron- or glial-specific ablation of secreted renin does not affect renal renin, baseline arterial pressure or metabolism Physiol Genomics 2010
84. S. Yagi, M. Akaike, K. Aihara, T. Iwase, S. Yoshida, and Y. Sumitomo-Ueda High plasma aldosterone concentration is a novel risk factor of cognitive impairment in patients with hypertension Hypertens Res 34 2011 74 78
85. C.E. Zaugg, P.H. Louie, V. Tschinke, S. Stefan, R. Mah, and A. Stojanovic Preclinical pharmacokinetic and pharmacodynamic characterization of SPP635, a new direct renin inhibitor Hypertension 2008, Joint Congress 18th Scientific Meeting of the European Society of Hypertension and the 22nd Scientific Meeting of the International Society of Hypertension Berlin, Germany 2008